Tag: Safinamide Mesylate supplier

Background: This phase Ib trial assessed safety, tolerability, and maximum tolerated dose (MTD) of figitumumab (CP-751,871), a completely human monoclonal antibody targeting the insulin-like growth factor type 1 receptor (IGF-IR), in conjunction with docetaxel. optimum tolerated dosage (MTD) had not been reached, as well as the maximal feasible dosage and recommended stage II dosage (RP2D)…